WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
State-of-the-art laboratory to support ingredient and specialty chemical innovation, product formulation application development and more sustainable solutions across Europe and beyond
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
Clinical trial supply company strengthens its presence in the European Union
BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
Keytruda plus Lenvima is also approved in the U.S. and Europe for the first-line treatment of adult patients with advanced RCC.
100% efficacy against severe Covid-19 disease and hospitalizations
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Subscribe To Our Newsletter & Stay Updated
